Press Release: *TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints *Promising Anti-MRSA Activity and Excellent Pharmacokinetic Profile Demonstrated in a Phase II Proof of Concept trial ---Quote--- TAIPEI, Taiwan, March 12...
More...